Clinical Report: Link Between Apolipoproteins and Retinal Arteriosclerosis
Overview
This study investigates the association between apolipoproteins and retinal arteriosclerosis in a health examination cohort of 4,938 adults. Findings indicate that higher levels of ApoB and the ApoB/ApoA1 ratio are linked to increased prevalence of retinal arteriosclerosis, particularly in older adults.
Background
Retinal arteriosclerosis serves as a non-invasive marker for systemic microvascular damage and early atherosclerosis. Understanding the relationship between apolipoproteins and retinal health is important. Traditional lipid measures may not fully capture the atherogenic burden, making apolipoproteins a valuable focus for research.
Data Highlights
Group
Prevalence of Retinal Arteriosclerosis
Males
13.98%
Females
8.57%
Key Findings
Retinal arteriosclerosis prevalence was 13.98% in males and 8.57% in females.
Individuals with retinal arteriosclerosis had significantly higher ApoB levels.
ApoB (per 1-SD increase) was associated with retinal arteriosclerosis (OR 1.12, 95% CI 1.01–1.24).
ApoB/ApoA1 ratio (per 1-SD increase) was also linked to retinal arteriosclerosis (OR 1.14, 95% CI 1.03–1.27).
Significant associations were found in adults aged ≥45 years, non-smokers, and non-hypertensive individuals.
Clinical Implications
The findings suggest that integrating apolipoprotein profiling into cardiovascular risk assessments may enhance early detection of microvascular damage. This could lead to improved strategies for identifying individuals at risk for cardiovascular events.
Conclusion
The study establishes a link between apolipoproteins and retinal arteriosclerosis.
